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Abstract
Protein structural dynamics have been closely tied to the molec-
ular mechanisms controlling for example enzyme activities. In my
work, I have mainly studied the bacteriophytochrome from Deinococ-
cus radiodurans. Phytochromes are photoreceptors that monitor the
level, intensity, duration and color of environmental light to regu-
late numerous fundamental photomorphogenic processes in plants,
fungi, and bacteria. In order to monitor the dynamic nature of such
proteins, they are preferably investigated in solution. NMR and IR
spectroscopy are ideal techniques for studying proteins in solution,
but can suffer from spectral overlap on larger systems.
To investigate large proteins, such as the phytochromes studied
in this thesis, biochemical modifications can be applied. Introduction
of isotopes, either uniformly, amino acid-selectively or site-selectively
make it possible to study the dynamics of large proteins even down
to selected residues.
In this thesis, I developed and applied uniform, amino acid-selective
and site-selective methods to isotopically label proteins, primarily a
bacteriophytochrome. Solution NMR and IR spectroscopy were then
applied to probe the structural dynamics of these proteins. The in-
vestigations reveal both how structural heterogeneity couples to the
photomodulation in phytochromes, and how isomerization of the
chromophore is linked to the global structural rearrangement in the
sensory receptor. Further, the bacteriophytochrome knot region was
investigated, and the results suggest the knot as a novel signaling
pathway in phytochromes.
Site-selective isotope labeling, together with femtosecond IR spec-
troscopy, could also confirm an intermediate state in GFP fluorescent
signaling.
My work has enabled spectroscopic investigations to monitor ac-
tive sites and structural dynamics of proteins in a highly selective
manner. It revealed structural and dynamical information underpin-
ning the function of phytochrome photoreceptors.
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Chapter 1
Introduction
1.1 Let there be light
Light is needed for almost all life on Earth, and evolution has made
sure to take advantage of the photons released by the sun that reaches
our pale blue dot. Light is used by life to drive photosynthesis, vi-
sion, signaling, controlling our day-night cycle and is also stored as
chemical energy within the cells. Since light comes in different wave-
lengths, it has been crucial for life to develop ways of absorbing light
from a broad spectrum of colors. The various ways organisms take
advantage of light are of highest scientific interest as it is a key con-
cept for understanding life itself [1].
Photosynthesis is one of the crucial ways life has found to utilize
light energy. The light is absorbed, and through a series of chemi-
cal reactions the energy is transformed into chemical energy such as
ATP. One of the side products of this reaction sequence is O2, for
which most higher animals are forever grateful.
In order for photosynthesis to progress, sensing the variation in
light conditions has also been of crucial importance. As plants stand
deeply rooted in the ground, unable to move, they need to be able
to detect whether something grows in front of them and gives shade,
thereby hindering the vital photosynthesis. In response to this change
in light they need to change how they grow, instead of another leaf
perhaps a longer stem is better to get out of the shade. Hence, a way
to sense different levels of shade is of utmost importance for plants,
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and specific light-sensing biomolecules are responsible for this cru-
cial task. These light-sensing biomolecules have been the main focus
in my work.
1.1.1 Light sensitive proteins
As mentioned above, life has found many ways to capitalize on the
energy coming from the sun. There are specific types of proteins
which can sense light. They are responsible for absorbing the energy
of the photon and transforming it to various biochemical signals de-
pending on the proteins structure and function, and the wavelength
of the photon. It is not surprising then that the number of proteins
involved in capturing or sensing light numbers in the thousands [2].
To optimize the light uptake different organisms have had to de-
velop proteins with different spectral characteristics, e.g. proteins
that absorb in various spectral windows, or different wavelengths.
Proteins are built up from amino acids, none of which absorb light
in the visual range. Therefore certain cofactors absorbing visual light
have been incorporated into the proteins throughout evolution. These
cofactors are known as chromophores. The chromophores are able
to absorb light over a broad wavelength range (Figure 1.1), and it de-
pends on the structural details of the protein on how the energy is
subsequently transferred and used in signaling.
1.1.2 Proteins: structure — function — dynamics
The name "protein" was first mentioned by the Swedish scientist Jöns
Jacob Berzelius [3]. Proteins are responsible for the majority of the
biochemical processes taking place in nature. They control every-
thing from vision and neurotransmission to sending flashes of light
and telling plants they are currently growing in the shade. The dif-
ferent proteins in our body alone numbers in the tens of thousands,
each responsible for a specific function. Malfunctioning proteins is
the cause of many diseases. Therefore, proteins have been a major
research target since already the 1800’s.
2
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Figure 1.1: Selection of chromophores and their spectral absorption, rang-
ing from UV to near-IR.
The structure of proteins is closely linked to their functions, a
fact that has been known for decades. Consequently much effort has
been put into determining the three-dimensional structures of these
biomolecules. As a result the number of protein structures in the on-
line databank currently numbers in the hundreds of thousands [2].
A clear majority of the structures solved to date were solved us-
ing X-ray crystallography. Protein crystals are illuminated with a high-
energy X-ray beam, which causes diffraction patterns correlating to
their structure [4]. In order to use this method, the protein first has
to be crystallized, which is not trivial. The method can determine a
protein structure to a very high resolution, but suffers from the very
unnatural environment of crystals.
To clarify, when talking about structures special care has to be
given to the fact that the word relates to several levels. The primary
structure is the amino acid sequence, the secondary structure cor-
responds to whether the peptide forms for instance α-helices or β-
sheets, which is mostly determined by the primary structure. The
tertiary structure is the 3D structure of a single-polypeptide protein
and what is usually referred to as protein structure. The 3D protein
structure is therefore mostly dependent on the individual secondary
3
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structure elements, while the quaternary structure describes the rel-
ative alignment of multi-polypeptide protein domains in large pro-
teins.
However, knowing the complete 3D structure of a protein is in
many cases not enough to understand how it functions. This could
be compared to having a photograph of a car and trying to figure out
what the car does and how it works. Filming the car in action is much
more informative. Proteins are not rigid structures, they constantly
change conformation and various substates exist in an equilibrium
which can be perturbed to shift the conformational equilibrium to-
wards one particular state. As with the car example, "filming" the
protein in action could reveal much more information as the function
of the protein is more closely related to its dynamical nature than the
rigid crystal structure [5, 6].
The dynamics–function relationship is extra clear when it comes
to the group of intrinsically disordered proteins. This group of pro-
tein consists of fully unstructured to partially unstructured proteins,
but nevertheless serve vital functions in cellular control mechanisms
and signaling [7, 8].
1.1.3 Probing protein dynamics
Other techniques than X-ray crystallography, either complementary
or by themselves, are needed to determine the function of a pro-
tein. Preferably the proteins should be studied in as natural environ-
ment as possible, which often means in solution. Such techniques as
nuclear magnetic resonance (NMR) and infrared (IR) spectroscopy,
small- and wide-angle x-ray scattering, or circular dichroism can be
used in order to probe the structure and dynamics of proteins in so-
lution in order to elucidate their function and physiological role [5,6].
In order to successfully probe dynamics of active sites or distin-
guish interesting domains, the proteins themselves may have to be
modified. However, special care has to be taken that these modifica-
tions does not alter the proteins functionality. Otherwise all obtained
results might not reflect the natural function of the protein studied.
4
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Modifications can be as simple as truncation of certain domains, or
advanced as incorporation of unnatural amino acids [9, 10].
For some of the above mentioned techniques, isotope labeling
of the sample is needed as isotopes usually won’t disturb the func-
tion. NMR spectroscopy requires a specific magnetically active type
of isotope in order to detect the signal, and IR spectroscopy can be
greatly helped by the introduction of certain isotopes at interesting
sites. However, isotope labeling is in many cases not a trivial task,
something that will be further detailed in Chapter 3.
1.2 Phytochromes
1.2.1 Discovery and background
The first indication of a photosensory control in plants was found as
early as the 1920’s when Garner and Allard reported on how plants
responded to variations in the day-night cycle, with regard to growth,
flowering and fruition [11]. The next major step was taken by Borth-
wick et al. in 1952, when they showed how seed germination could
be controlled by red light and furthermore could be inhibited by il-
lumination with far-red light. They even determined the absorbance
maximum (Figure 1.2 shows the absorbance spectrum for Deinococ-
cus radiodurans phytochrome monomer) for the activation and deac-
tivation to 660nm and 710-750nm respectively [12].
Shortly after the biomolecule responsible was isolated and pu-
rified, it was named Phytochrome. Phytochromes are photosensory
proteins and have since their original discovery been found in vari-
ous other organisms such as fungi, bacteria and algea, but so far not
in animals or archaea [13–17]. The well-spread hypothesis that plant
chloroplasts originated as a symbiosis with a photosynthetic bacteria
which was later incorporated into the cell lead researchers to believe
that the phytochrome actually originated from a prokaryote [18, 19].
5
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Figure 1.2: Pr and Pfr state of Deinococcus radiodurans phytochrome
monomer. Resting (Pr) state shows an absorbance maximum at 700nm, while
light-activated (Pfr) state shows a maximum at 750nm.
1.2.2 Structure and function of phytochromes
The reason behind the different responses to red and far-red light lies
in the two meta-stable forms of phytochromes: one absorbing red
light, the other far-red, named Pr and Pfr, respectively (Figure 1.2).
The phytochrome family also shares a combination of highly con-
served domains, these seem to be modular (see Figure 1.3 for a layout
of the various modular compositions of different phytochromes) as
various phytochrome families either lack certain domains or contain
duplicates. The conserved domains building the photosensory core
of the main family are: PAS (Per/Arnt/Sim), GAF (cGMP phospho-
diesterase/Adenyl cyclase/Fhl 1) and PHY (Phytochrome specific).
In this protein family we find plant phytochromes, bacteriophy-
tochromes, fungal phytochromes, diatom phytochromes and Cph1
from cyanobacteria. Cyanobacteria also utilize two other families of
phytochromes which lack either the PAS domain, or both PAS and
PHY. These are called Cph2s (after the first member of the family,
Synechocystis Cph2) and CBCRs (cyanobacteriochromes), respectively
[20,21]. Despite their differences in composition, all known phytochromes
exist as homodimeric complexes, and are soluble proteins. In addi-
tion to the photosensory core, phytochromes also contain variations
of C-terminal output domains, in bacteriophytochromes these are
in many cases histidine kinases [22, 23], and may or may not have
6
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Figure 1.3: a) Homodimeric modular structure of phytochromes, consisting
of PAS (dark green), GAF (green), PHY (light green) and output module (yel-
low). b) Phytochromes are divided in three classes determined by their mod-
ular structure.
an N-terminal extension domain thought to be involved in signal-
ing [20, 24].
Phytochromes also utilize variations of linear tetrapyrroles, so
called bilins, as chromophores. These are obtained by oxidative degra-
dation of heme to biliverdin (BV), a chromophore used by bacterio-
phytochromes and fungal phytochromes. The BV can then be fur-
ther metabolized by ferredoxin-dependent bilin reductases into ei-
ther PCB (phycocyanobilin) or PφB (phytochromobilin) which are
used by cyanobacteria or plant phytochromes, respectively [20, 24].
The chromophore is covalently bound to a cysteine, and although
it can be bound to either the PAS (bacteriophytochromes) or GAF
(cyanobacterial and plant phytochromes) domain, it resides within
the GAF domain.
While the biological function of plant phytochromes is well-studied
[25], the biological function of bacteriophytochrome from non-photosynthetic
bacteria remains poorly understood. This, together with their simple
7
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modular composition, resemblance to plant phytochromes, less com-
plex photocycle and ease to produce in large quantities, has made
them a prime target of investigation. If the complete biochemical
mechanism of phytochromes can be elucidated, it would open up
a world of possibilities to control and manipulate many biological
functions of plants at atomic level.
Bacteriophytochrome from Deinococcus radiodurans (DrBphP) was
the first phytochrome fragment (PAS-GAF domains only) to be crys-
tallized, and therefore the first one to have the structure resolved at
an atomic level [26]. Since then, DrBphP has been used as a model
system for studying phytochromes, and several structures of differ-
ent modular composition have been resolved [27–32].
The PAS-GAF-PHY fragment seen in Figure 1.4 shows a compar-
ison of crystal structures of the Pr and Pfr states in DrBphP. The crys-
tal structures have helped to shed light on many aspects of the phy-
tochromes function. Among them the photochemistry of the chro-
mophore involves an isomerization of the C15=C16 double-bond and
thereby a flip of the D-ring (tetrapyrrole rings denoted A-D count-
ing from the cysteine-bond) [27], which had previously been pro-
posed [33, 34].
The crystal structures also showed an opening of the PAS-GAF-
PHY dimer and rearrangement of a conserved loop region called
"tongue" from β-sheet to α-helix upon light illumination, which was
proposed to be significant for signal transduction [31]. In Paper I we
investigate the role of the tongue in transducing the signal and find
that the tongue exerts a stabilizing effect in Pfr state by going from
a structurally highly dynamic form to more rigid. We also show that
the first arm is a β-strand, and not random coil, in Pfr and gets struc-
turally more rigid, while the other changes conformation to α-helical.
Another interesting finding was the region in the PAS-GAF do-
main which forms a knot, a feature which is rare in protein structures
[26]. The significance of this knotted region has still not been com-
pletely resolved, although it has been speculated to have a stabilizing
effect on the PAS-GAF interface and chromophore binding pocket. In
terms of how the signal is transduced from the chromophore to the
output domain has not yet been resolved, the knot could play a more
8
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Figure 1.4: DrBphP crystal structure of PAS-GAF-PHY fragment. The dif-
ferent domains PAS, GAF and PHY are colored orange, cyan and green re-
spectively. In a) the Pr structure is depicted (PDB ID 4O0P), where b) shows
a zoom in of the tongue in β-sheet conformation. c) shows the Pfr structure
with the dimer splayed apart, and a zoom in on the tongue in d) shows the
change in conformation to α-helical.
significant role than believed. In Paper II we investigate the role of
the knot, and propose a novel signaling pathway stretching from the
propionic acid on the biliverdin B-ring, through the knot, to the he-
lical spine connecting the PAS and GAF domains with the PHY and
output domains.
As previously mentioned, the light absorption by the chromophore
initiates an isomerization and flip of the D-ring. This encompasses
the photocycle of the phytochrome, and includes in addition to the
two meta-stable Pr and Pfr states several intermediate states (see Fig-
ure 1.5). Upon red-light illumination, the Lumi-R state is formed in
picoseconds, whereafter the Meta-R state is formed in a matter of
9
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microseconds. The meta-stable Pfr state is reached within a few mil-
liseconds, a state which is stable for minutes up to hours or until a
far-red light initiates the second half of the photocycle (Pfr→ Lumi-F
→Meta-F→ Pr).
Figure 1.5: DrBphP photocycle The two meta-stable states Pr and Pfr, and
the intermediate states Lumi-R, Meta-R, Lumi-F and Meta-F.
The light-activated state reverts back to resting state in darkness
over a matter of minutes up to hours in a process called thermal or
dark reversion. For phytochromes such as DrBphP, the resting and
light-activated states are Pr and Pfr, respectively. There are however
phytochromes which have the opposite thermal reversion and Pfr
state as resting state. These phytochromes are categorized as "bathy"
phytochromes while the Pr resting state phytochromes are catego-
rized as "canonical".
Even though the structures of the two meta-stable Pr and Pfr
states are well-known and the photocycle has been determined, the
structural rearrangements during the intermediate steps are still poorly
understood. In Paper III, we investigate the dynamics of the interme-
diate states and show how the hydrogen bonding network between
the chromophore and protein changes during the course of the pho-
tocycle and how this couples to the global structural rearrangement
of the phytochrome.
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1.3 Green Fluorescent Protein
1.3.1 Discovery and background
Green Fluorescent Protein was first discovered in 1955 by Daven-
port and Nicol in the jellyfish Aequorea victoria when they reported
a green fluorescence from the jellyfish upon UV illumination [35]. It
was isolated in 1962 by Shimomura et al. [36] and has since then been
discovered in other organisms. The green fluorescent protein (GFP)
from Aequorea victoria remains the most widely used model system
though. And although GFP has been known for many decades and
is used heavily as a molecular tool, the biological function of this flu-
orescent protein has still not been determined.
1.3.2 Structure of GFP
The protein itself consists of 11 β-strands which together form a β-
barrel type structure, as was discovered when the structure was solved
in 1996 by Yang et al. [37]. It also has a self-assembling chromophore
formed by the cyclization of serine 65 - tyrosine 66 - glycine 67 [38]
and therefore does not need the addition of an external chromophore
and can be readily expressed and detected in whole cells.
GFP has for a long time been used as a molecular tool in protein
science, and is a highly overexpressing protein. A lot of effort has
been put into changing its fluorescent properties (as was done by
Crameri in 1996 [39]) to be used as a biochemical tool. It is being used
as a co-expression partner, gene expression marker, co-localization
marker, as a model system for developing new biochemical methods
(as was done in Paper IV) and much more [40]. In Paper IV and V,
GFP was used to screen for optimal expression conditions in a cell-
free expression system, where the GFPcyc3 mutant from Crameri et
al. was used [39].
Although GFP has been studied for a long time, its special spec-
tral and fluorescent properties are still intensely studied [41]. GFP
fluorescence is dependent on the self-assembly of the chromophore,
also called maturation. The key amino acid in the chromophore is
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tyrosine 66, which absorbs the photon causing the delocalization of
an electron in the side-chain ring. This excited state lives for a few
picoseconds before the phenolic hydroxyl group gets deprotonated
(through excited-state proton transfer) and the proton gets transferred
to glutamic acid 222 via a water molecule and serine 205. This mech-
anism has been suggested earlier [42,43] and was confirmed in Paper
IV.
1.4 Voltage-gated sodium channels
Voltage-gated ion channels is a superfamily of membrane proteins,
which are further classified by their ion selectivity (e.g. sodium, potas-
sium and calcium channels). The different classes are closely related
and are responsible for the generation of electrical signals and prop-
agation of action potentials in the neurons and other excitable cells.
They have three distinct functional states, which were described by
Huxley and Hodgkin in 1952 [44] as activated, inactivated and rest-
ing states.
These channels were first discovered in eukaryotes, but it was
not until the discovery of a prokaryotic voltage-gated sodium chan-
nel (Navs) that structural determination became feasible as it enabled
higher protein production yields [45, 46]. Bacterial and human Navs
share a 20-25% identity and almost identical hydrophobic profiles
and predicted topologies. Due to this, bacterial orthologues are ex-
pected to be a good model system for human Navs.
Although the structure has been solved for a bacterial Nav in the
open conformation [47], the actual mechanism for ion transport and
selectivity has not yet been completely understood. Molecular dy-
namics simulations have yielded a wide range of proposed mecha-
nisms for ion transport, as can be seen in the case of potassium chan-
nels [48, 49].
A way to elucidate the mechanism would be to use advanced
labeling techniques of residues residing in the pore of the channel,
with the help of in vitro (or cell-free) protein synthesis. However, in
vitro production of prokaroytic voltage-gated sodium channels had
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not previously been reported. In Paper V we show that we can pro-
duce milligram quantities of a functional pore-only sodium channel
from Silicibacter pomeroyi with the help of in vitro protein synthesis,
which opens up for advanced labeling of Navs.
1.5 Scope of this thesis
In this thesis uniform, amino acid-selective and site-selective iso-
tope labeling, together with NMR and IR spectroscopic techniques
have been used to study dynamics of proteins, with a focus on the
Deinococcus radiodurans phytochrome. The thesis is structured as fol-
lows:
Chapter 2 will describe the different expression and purification
systems used throughout the work listed below.
Chapter 3 will focus on the various isotope labeling techniques used,
and how they can be applied.
Chapter 4 will give a brief introduction to the basics of the differ-
ent NMR experiments, and deal with the selected vibrational spec-
troscopy techniques I have used in this work.
Chapter 5 will summarize, conclude and give an outlook for future
prospects
Paper 1 investigates the role of the loop region called tongue in a
bacterial phytochrome. This was accomplished with advanced iso-
tope labeling techniques, including uniform and in vivo amino acid-
selective labeling. The structure and dynamics of the isotope labeled
phytochrome were probed with NMR spectroscopy.
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Paper 2 describes a novel signaling pathway in phytochromes, con-
necting the biliverdin chromophore with the conserved knot and fur-
ther the helical spine and output domain. Uniform isotope label-
ing was performed on the bacterial phytochrome, and NMR spec-
troscopy was used to probe the structure and dynamics.
Paper 3 shows how isomerization of the chromophore is linked to
the global structural rearrangement in the bacteriophytochrome sen-
sory receptor. Uniformly and in vitro amino acid-selectively labeled
phytochromes were subjected to time-resolved FTIR spectroscopy.
This revealed how the hydrogen-bonding network in the chromophore
binding pocket changes throughout the photocycle.
Paper 4 describes an efficient way to site-selectively isotope label
proteins with the help of cell-free protein synthesis. The method was
used to site-selectively label tyrosine 66 in GFP which was probed
with femtosecond IR spectroscopy. We could confirm an intermedi-
ate state between photoexcitation and deprotonation.
Paper 5 details how to synthesize a fully functional membrane span-
ning pore-only sodium channel with cell-free protein synthesis. The
method opens up the possibility to site-selectively monitor the active
site with isotope labeling techniques.
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Protein expression and
purification
Production of proteins is the basis of all biochemical and biophysi-
cal experiments. Different biophysical applications require different
amounts of protein, from single particles up to several grams for the
really sample-intense experiments. Many proteins have low expres-
sion levels in their native cells. Finding ways to overexpress these
proteins is a prerequisite for efficient biochemical studies.
Furthermore, some experimental methods require specific modi-
fications to be made in the proteins, such as labeling with isotopes or
unnatural amino acids. Developing and optimizing production pro-
tocols to meet the specific needs is therefore crucial, and the produc-
tion of proteins is far from a trivial task.
In addition to protein production, protein purification is in most
cases needed and the purification steps can also pose major chal-
lenges. Also here much effort is put into developing and optimizing
protocols tailored for a specific application.
In Section 2.1 and 2.2 I will detail how these challenges were over-
come. Both the in vivo and cell-free protein expression systems de-
veloped and used in this work will be explained, and the benefits for
using one over the other for our NMR and IR spectroscopic studies.
Finally in Section 2.3 I will discuss the purification steps taken and
optimized for the proteins in my work.
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2.1 In vivo recombinant protein expression
There are several overexpression systems in daily use at research lab-
oratories. Both eukaryotic and prokaryotic systems as their respec-
tive proteins may differ in post-translational modifications or require
different chaperone proteins in order to reach their native fold.
2.1.1 Recombinant protein expression in E. coli
The most widely used expression system is based on Escherichia coli,
and the reasons for that are many: E. coli grow extremely fast, and
can under optimal conditions double in cell density every 20 minutes
[50]. Theoretically, E. coli can reach cell densities as high as 200 grams
per liter of media, although in practice only a small percentage of
that number is reached [50, 51]. Growth media for E. coli can easily
be prepared and at a very low cost. Transformation of exogenous
DNA vectors into E. coli can be performed in a matter of minutes or
hours [52, 53].
DNA vectors, or plasmids as they are also called, are the circular
DNA molecules in which to insert the gene of interest. A large selec-
tion of different vectors have been developed depending on which
type of expression system used, prokaryotic or eukaryotic, in vivo or
cell-free. What type of gene is inserted, large or small, and for what
purpose the vector will be used, cloning or expression. A commonly
used plasmid family for overexpression of proteins is the pET vec-
tors, derived from the pBR322 vector developed already in 1977 [54].
In the pET vectors, gene expression is under control of the T7 pro-
motor region from T7 bacteriophage, a site recognized by the highly
specific orthogonal T7 RNA polymerase. The T7 promotor sequence
is rarely encountered outside the T7 bacteriophage genome, and as
such the overexpression is highly specific for the gene downstream
of the T7 promotor sequence. This means we can reliably overexpress
the target protein while keeping endogenous protein expression to a
minimum.
The T7 RNA polymerase is controlled by the lac operon, it is
triggered by the addition of Isopropyl β-D-1-thiogalactopyranoside
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(IPTG) which binds to the lac repressor and thereby frees the DNA
for transcription and following translation. It is, however, not part
of the pET vectors and needs to come from another source (see next
paragraph). In addition, the pET vectors also contain resistance to
ampicillin or kanamycin for efficient selection of cells containing the
vector.
For in vivo expression, a pET vector was the one selected in most
of the work in this thesis. In Paper IV an expression vector optimized
for cell-free protein synthesis (pIVEX2.4d) was chosen, for simplicity
and as reference for the cell-free synthesized proteins [55]. For Paper
V the protein was overexpressed in the plasmid which was gifted
(pHM3C-LIC), and had previously been shown to successfully work
as expression vector for Navs [56].
Transformation of the vector into host cells has been a standard
practice in biochemical work for decades, and it is therefore not sur-
prising that the number of different cell lines for recombinant pro-
tein expression is huge. For E. coli a good starting candidate and also
the most widely used would be the BL21(DE3) strain, a strain which
can be traced back through scientific articles at least 100 years [57].
During those years, it has been subjected to numerous modifications
to improve recombinant protein expression, among others certain
genes coding for proteases which target foreign and extracellular
proteins have been removed. BL21(DE3) also contains the gene for
T7 RNA polymerase in its chromosomal DNA, and is essential for
overexpression of proteins controlled by the T7 promotor region [52].
Note that even within the BL21(DE3) cell line there are strain vari-
ations. Rosetta(DE3) is for instance optimized for prokaryotic expres-
sion of eukaryotic proteins, and BL21 Star (DE3) increases the stabil-
ity of mRNA (used in Paper IV). It is therefore of utmost importance
to choose the expression host with care, as the protein yields can vary
greatly. As the work in this thesis is concerned with overexpression
of prokaryotic proteins, variations of the BL21(DE3) cell line were
used.
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Finally, after choosing the correct vector and expression host, ad-
ditional factors such as growth medium, temperature and expres-
sion time will have an effect on the cell growth and in extension pro-
tein yields. In case of overexpression without further modifications
Lysogeny Broth (or LB medium) is the most commonly used growth
medium. It has been in use since the 1950’s when Bertani first pub-
lished the recipe [58].
As was the case in Paper I, II and III, where modifications to the
protein during expression are needed, another medium such as the
M9 minimal medium might be used. These modifications could be
various forms of isotope labeling (Paper I, II and III), further de-
tailed in Chapter 3.
The M9 minimal medium is based on a phosphate buffer contain-
ing sodium, potassium, calcium, magnesium and ammonium (which
can be exchanged for isotope labeled ammonium for uniform label-
ing). Glucose is normally used as a carbon source, which also can be
exchanged for various labeled versions for uniform labeling. Addi-
tional nutrients such as trace metals, vitamins and amino acids (la-
beled amino acids for amino acid-selective labeling) can be added if
necessary for the specific application. Normal water can also be ex-
changed for D2O, in order to deuterate the expressing protein. This
medium gives a better control of the conditions, but usually results
in slower growth and lower expression yields compared to E. coli
grown in LB medium.
2.2 Cell-free protein expression
An alternative to using living cells as protein factories is to extract
the components necessary for protein synthesis, such as the ribo-
some and various enzymes (see Figure 2.1), from the cells. The so-
called cell-free extract is then mixed in an appropriate vessel with
your gene of interest. This technique is called cell-free protein ex-
pression (CFPE) or in vitro protein expression.
As will be described in following sections and was introduced in
the previous section, the choice of expression system is something
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that requires a lot of consideration. In the work for this thesis I have
taken advantage of the strengths of both in vivo and cell-free expres-
sion systems.
2.2.1 History of cell-free expression
CFPE has been used in biochemical studies since the 1950’s when it
was discovered that protein expression continued in disrupted cells.
It was for instance used by Zamecnik and colleagues when they dis-
covered the tRNA [59] and elucidated the biochemistry behind pro-
tein synthesis (for instance they showed that protein synthesis takes
place at the ribosomes). CFPE became widely used after Nirenberg
and Matthaei demonstrated a way to add an exogenous template
in the form of RNA [60], although their work was mainly focused
on studying the genetic code. In 1973, Zubay further optimized the
CFPE system by digesting endogenous nucleic acids in the prepa-
ration of the cell-free extract and thereby reducing the expression of
other endogenous proteins [61]. Further developments of the system,
such as the addition of the orthogonal T7 RNA polymerase and T7
promotor site, as described in Section 2.1, were performed during the
70’s and 80’s.
A major advance in cell-free protein expression came in 1988 by
Spirin et al. when they developed a continuous expression system
(called continuous-flow cell-free) where the substrates were continu-
ously added and the products removed [62]. This completely revolu-
tionized the CFPE field, as up until that point all expression had been
performed in so called batch mode, where all components are added
in the beginning. The batch mode had several drawbacks as the re-
action ran out of substrates, and by-products which acted inhibitory
accumulated which resulted in a synthesis time limit of maximum an
hour. With this new system, synthesis could be maintained for many
hours, which resulted in higher protein yields. The continuous-flow
cell-free system works by having a small reaction chamber over which
a continuous flow of substrates is kept, while the products are sepa-
rated away from the reaction chamber via a porous membrane [62].
19
Chapter 2. Protein expression and purification
This continuous flow of supplements can be a disadvantage. In
the case of expensive isotope labeled substrates for labeling of pro-
teins, a continuous flow is simply not cost effective. Here, batch mode
has a distinct advantage.
Another adaptation of the continuous system is called continuous-
exchange cell-free, where the major difference is the reaction taking
place in a dialysis chamber and hence the polypeptide product re-
mains in the reaction chamber throughout the reaction, while smaller
by-products get replaced with fresh substrates through the dialysis
membrane [62, 63]. All three expression systems (batch, continuous-
flow and continuous-exchange cell-free) are still being used with smaller
modifications.
For the work done in Paper III, IV and V, we have chosen the
batch mode approach. For Paper III and IV the cost of externally
supplied components (mainly the isotope labeled amino acids or aminoacyl-
tRNAs) would have been unfeasible with the other approaches. For
simplicity, the same setup was then used also in Paper V.
2.2.2 The cell-free system and its components
The cell-free system is an in vitro system, meaning the transcription
and translation reactions takes place outside of living cells. The dif-
ferent components needed for the system to work are externally sup-
plied, and can vary with the application. In Paper V, detergents were
added to the reaction, as a membrane protein was expressed.
The system is most usually built up from E. coli, wheat germ
or rabbit reticulocytes. Systems from insect cells, yeast and tobacco
are other examples being used and technically systems from any
kind of organism should work as long as they provide the necessary
translational machineries [64,65]. The various systems have different
strengths and weaknesses. For example the E. coli system, used in
this work, is by far the most robust but has huge problems with post-
translational modifications. The choice of system needs to be based
on the protein of interest and applications.
Cell-free extracts consist of the major components from a cell lysate.
The major components needed for protein expression are ribosomes
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Figure 2.1: The CFPE system A schematic view of the CFPE system devel-
oped by Pedersen et al. Printed with permission from Dr. Pedersen.
for the actual protein synthesis, translation factors (initiation, elon-
gation and release factors), aminoacyl-tRNA synthetases to load the
tRNA with amino acids and various kinases to convert the NMP’s
and NDP’s to NTP’s. A schematic view of the components in a CFPE
system can be seen in Figure 2.1.
Endogenous nucleic acids are degraded during an incubation step
and removed either during centrifugation or dialysis in the extract
preparation. There are variations in the preparation of this cell-free
extract and the most common one is based on an extract called S30
extract created by Nirenberg in 1963 with small modifications [61,66,
67].
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The S30 extract is a so called cleared extract, meaning lipids and
membrane components have been removed during an ultracentrifu-
gation step (at 30000g and hence the name S30). However, the prepa-
ration of this lysate is both tedious and costly (about 30% of the to-
tal cost of CFPE with S30 extract comes from the extract prepara-
tion) and in 2006 Kim et al developed a simplified extract they called
S12 [68]. They noted that the E. coli lysate worked in its non-treated
form.
Based on this, they added a few simple preparation steps such
as a low-speed centrifugation, short incubation and dialysis, which
resulted in a 60-80% reduction of preparation cost and significantly
higher expression yields [68]. There is the drawback of slightly higher
background expression of endogenous proteins, and it does not seem
to work well for all cell lines. It also still contains lipids and other
membrane components, and is thus a cloudy extract, which could
influence the expression of especially membrane proteins.
In addition to the cell-free extract, other components are needed
for the CFPE to work: template DNA containing the gene of inter-
est, RNA polymerase, amino acids, tRNA and an energy source. As
template DNA purified plasmid DNA or PCR products can be used.
Amino acids and tRNA can be easily purchased, and unnatural or
isotope labeled amino acids can be added (as was done in Paper I,
III and IV).
Regarding the RNA polymerase, the T7 phage system can be used
with great results (as described in Section 2.1). When it comes to en-
ergy source a lot of work has been put into developing an efficient en-
ergy regeneration system. The cell uses high-energy phosphate com-
pounds to generate ATP (adenosine triphosphate).
As certain by-products such as inorganic phosphates act inhibitory
on the expression, these need to be removed. In continuous-flow
and continuous-exchange cell-free this is taken care of by continu-
ous exchange, but for batch mode the accumulation has long been
a problem. Several different regeneration systems have been devel-
oped. For instance the Cytomim tries to mimic the cytoplasmic con-
ditions of the host cells and utilizes pyruvate as energy source and
thus does not generate inorganic phosphates as a by-product [69].
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Other systems utilize phosphoenolpyruvate, acetyl phosphate or cre-
atine phosphate together with pyruvate kinase, acetate kinase or cre-
atine kinase, respectively, to generate ATP from ADP.
Additional additives such as various cofactors, detergents (Paper
V), chaperone proteins and other interaction partners can also be
used with the E. coli CFPE system, depending on the need of the
protein of interest. A schematic view of a CFPE system is shown in
Figure 2.1.
Optimizations and modifications of the cell-free systems is still
ongoing, and there are now many specialized strains for CFPE, some
created with the help of the new revolutionary CRISPR/CAS9 sys-
tem [70–74]. The expression yields have reached up to around two
milligrams of protein per milliliter of reaction, and further develop-
ments will make CFPE more and more feasible for large-scale appli-
cations [73].
Recently, commercial CFPE-kits have also been developed as ed-
ucational tools for molecular biology and its central dogma utilizing
a freeze-dried version of the cell-free extract. Besides showing that
freeze-dried extracts, which are later rehydrated, are still active, this
will be of huge help in the coming years teaching a new generation
of scientists [75, 76].
A CFPE system was developed by Pedersen et al in 2011 [77], and
is schematically shown in Figure 2.1. This system is an E. coli based
system from the BL21(DE3) Rosetta strain with a modified S12 ex-
tract [68,77]. It is a batch system specifically optimized for expression
of proteins labeled for NMR studies. Further, the concentration of
creatine phosphate and key amino acids were optimized to improve
protein expression yields. Additional additives increasing the yields
include 2-oxoglutaric acid, succinic acid and malic acid. As a batch
system the effective reaction time is limited but the advantage being
cost effective isotope labeling, easy miniaturization, parallelization
and hence fast screening of optimal reaction conditions [78].
As was mentioned previously and will be described in Chapter 3
it was used for a number of isotope labeling techniques (Paper III
and Paper IV) and for these applications batch mode is more cost-
effective. Some advantages and disadvantages of using in vivo or
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cell-free expression, as well as our home-made CFPE system versus
commercial ones will be discussed in the next subsection.
2.2.3 Cell-free versus in vivo expression systems
When choosing which expression system to use, there are a lot of
considerations one has to take into account. As such, a comparison
between cell-free and in vivo expression systems is not completely
easy to do and is not meant to decide which system is better. They
both have their strengths and weaknesses for separate applications.
In the following subsection I will try to go through a few of the differ-
ences, and give a number of examples where one might choose one
expression system over the other.
Depending on what the final goal is, either a CFPE or in vivo
system might be chosen. The main advantage of CFPE is the open
expression system, which for example allows for advanced labeling
techniques (as was done in Paper III and Paper IV and will be fur-
ther discussed in Chapter 3) or expression of proteins which might
be toxic for the cells (or in concentrations toxic for the cell).
In addition, the time until ready protein sample is much shorter
compared to in vivo methods, and an NMR spectrum has been reached
within 90 minutes of CFPE reaction start [79]. This can be a huge
advantage for screening purposes. More generally time-scales of 2-3
hours from start to purification step is the standard, and a schematic
comparison can be seen in Figure 2.2.
The possibility to add detergents, lipids, nanodiscs or chaperone
proteins have also opened up the possibility of expressing membrane
proteins (a fact I took advantage of in Paper V when I expressed
a pore-only sodium channel with CFPE), which in vivo can cause
cytotoxicity or be non-functional or even aggregate due to misfold-
ing [80, 81].
The ease of high throughput screening with CFPE is also valuable
to find optimum expression conditions. In addition the environment
of the reaction is open for changes such as in pH, redox potential
and temperature, as long is it does not hinder the transcription and
translation reactions [64, 77].
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Figure 2.2: Comparison of CFPE and in vivo reaction times A schematic
comparison of CFPE versus in vivo expression systems. The time for extract
preparation is around 2-3 days, and one 20 liter batch is enough for roughly
1 liter of CFPE reaction. When the extract has been prepared, the synthesis
reaction takes less than two hours, in comparison to in vivo expression which
normally lasts over a period of days.
A few drawbacks with the CFPE is the problems with expressing
large or highly complex proteins, which comes from either incom-
plete translation or insufficient post-translational modifications (in
prokaryotic systems) or low yields (which is the general norm for
eukayotic systems) [65]. These problems are consistently being ad-
dressed, and major improvements have been made over the last few
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years [65, 82–84].
In general, there is also the problem of choosing between continuous-
flow and continuous-exchange cell-free or batch mode. One will ei-
ther have long reaction times and higher yields but laborious setup
or simple setup but shorter reaction times and lower yields, respec-
tively.
There are commercial systems available , but the cost of commer-
cially available CFPE systems runs into the hundreds of dollars per
milliliter of reaction. This is also one of the drawbacks, but some-
thing that can be rectified by setting up and maintaining a home-
grown cell-free system as previously described [77]. By performing
large-scale cultures and preparations of the cell-free extract (20 liter
culture is enough for roughly 1 liter of CFPE reaction), the time spent
on this most laborious part (2-3 days) of using a home-made system
can be significantly reduced.
2.3 Protein purification
When expression system has been chosen and developed, the next
consideration will be regarding the purification of the protein. First
question would be if the protein at all needs to be purified? Some
applications can be performed on the crude lysate or even in whole
cells, while others require a completely pure protein sample.
For the applications in this thesis, some purification was neces-
sary, and the steps taken will be described in this section. An exam-
ple of unexpected difficulties one can encounter will be described in
the end.
Generally, protein purification starts with disrupting the cells, for
which there are several approaches. During this work, the cells have
been lysed by abruptly changing the external pressure while passing
them through a needle valve which causes the cells to disrupt. This
was achieved with the help of either a French pressure cell (named af-
ter the American Charles Stacy French), or an Emulsiflex (developed
by Avestin) which utilizes the same principle. Cell debris is removed
by centrifugation.
26
2.3. Protein purification
After centrifugation the lysate is normally further purified with a
combination of chromatographic techniques. These normally include
affinity, ion exchange (not used in this work), and/or size exclusion
chromatography.
In the case of DrBphP, biliverdin is added in excess under mildly
reducing conditions to the centrifuged cell lysate before chromato-
graphic purification, which spontaneously incorporates and cova-
lently binds the protein matrix.
For the use of affinity chromatography, a polyhistidine-tag has
been inserted either N- or C-terminally of the protein, and in this
work both versions have been utilized.
Affinity chromatography is usually the first purification step as
it can separate an affinity-tagged protein from a very crude mixture
of proteins. Normally a second chromatographic method is used to
yield a highly pure protein sample, and for this work SEC (size ex-
clusion chromatography) was the method of choice.
There are a few differences in the purification of CFPE and in vivo
expressed proteins, but in general the protocol do not change much.
As CFPE proteins are produced in an open system, there is no need
for an initial cell lysis step. There is however still major cell compo-
nents from the extract present, which need to be removed by cen-
trifugation. The purification then progress in the same fashion as for
in vivo expressed proteins, with affinity chromatography and follow-
ing SEC. Protein purity is then evaluated with gel electrophoresis.
A complication in regards to the CFPE of DrBphP was discov-
ered. The incorporation of biliverdin caused some difficulties as the
CFPE milieu was too strongly reducing. To solve this, the protein was
purified as an apoprotein following the steps described in the previ-
ous paragraph and a reducing agent was added in small molar excess
to the purified protein after which the biliverdin was added also in
excess. Excess biliverdin and reducing agent was later washed away
during a final buffer exchange step.
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Isotope labeling
Isotope labeling has been key to the work presented here. I have used
different labeling techniques in order to follow protein dynamics in
a site-specific way. With this we have been able to reveal new signal-
ing pathways and how changes in structural dynamics are used to
modulate signaling in phytochromes (Paper I and II). We have also
shown how isomerization of the chromophore is linked to the global
structural rearrangement in the same phytochrome (Paper III). And
with the help of site-specific isotope labeling of GFP we could con-
firm the existence of an intermediate state between photoexcitation
and proton transfer (Paper IV).
It is safe to say isotope labeling has been of crucial importance
to my work. This chapter aims at explaining the various isotope la-
beling techniques used throughout this thesis. The first section will
detail the uniform labeling of in vivo expressed proteins. Section 3.2
will describe amino acid-selective labeling, and the final Section 3.3,
site-selective isotope labeling.
3.1 Uniform isotope labeling in vivo
3.1.1 Applications with uniformly isotope labeled proteins
For several applications, two of them being used in this work (NMR
and vibrational spectroscopy), there is either a need or advantage to
uniformly isotope label proteins. For NMR spectroscopy (detailed in
Chapter 4), the sample needs to contain magnetically active nuclei
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in order to give detectable signals. In vibrational spectroscopy (also
described in Chapter 4), the isotopes will cause a shift of the protein-
associated peaks, making it possible to distinguish them from other
compounds which can give rise to overlapping peaks. In both cases,
isotope labeling will make it possible to directly follow protein struc-
tural dynamics in solution.
For the use of NMR spectroscopy, the nuclei need to be mag-
netically active (further explained in Chapter 4). The most common
magnetically active nuclei for protein NMR purposes are 1H, 13C,
15N, 31P, of which only 1H and 31P have a naturally high abundance.
For 13C (1.1% natural abundance) and 15N (0.4% natural abundance)
other means of enrichment are needed [85].
In small particles, where the concentration can be sufficiently high,
this is usually not a problem as it then is possible to measure on
the natural abundance. For large molecules with low concentrations,
such as proteins, this is not feasible, and the magnetically active nu-
clei need to be enriched in some fashion.
Uniform labeling for vibrational, or infrared (IR), spectroscopy
serves a slightly different purpose from labeling for protein NMR
spectroscopy. The inclusion of isotopes shifts the chemical bond vi-
brations to other frequencies, making it possible to identify the pro-
tein vibrational modes (discussed in Chapter 4).
Protein IR spectroscopy mostly suffers from spectral congestion
and difficulties in assigning the peaks to specific amino acids [86].
At a first glance, the uniform isotope labeling, which would shift all
peaks, would look fairly useless as a tool to help with this problem.
In Paper III, we show that the combination of uniformly labeled
apoprotein coupled with non-labeled chromophore gives an insight
into the molecular mechanism of signal transduction in DrBphP. This
is achieved by separating shifting protein peaks from non-shifting
peaks from the biliverdin chromophore. Another way of describing
this type of uniform labeling of the protein would be selective unlabeling
of the chromophore.
Uniform labeling has also been used in investigating protein-protein
and protein-ligand interactions, where one protein or ligand is left
30
3.1. Uniform isotope labeling in vivo
unlabeled and therefore certain regions, such as the so called amide I
bands, do not overlap between the two interaction partners [87–89].
Although uniform labeling with isotopes is used in vibrational
spectroscopy, other isotope labeling techniques outlined in Section 3.2
and 3.3 are considered more powerful as they give more site-specific
information [86].
3.1.2 Principles of uniform isotope labeling
In order to isotopically label proteins, one has to systematically con-
sider all alternatives listed in the previous chapter (Chapter 2).
Isotopically labeled precursors, such as [U-13C]-glucose and 15NH4Cl,
can be purchased from several vendors and can be used in substitu-
tion for the regular carbon and nitrogen sources. However, in order
to ensure a protein fully labeled with 13C and 15N, the regular source
also has to be removed and normal LB medium can therefore not be
used when expressing these proteins. Instead, various minimal me-
dia such as the M9 minimal medium, which was described in Sec-
tion 2.1, are utilized.
As large amounts of sample might be required for structural and
dynamical studies, the use of isotopically labeled media could be-
come very costly and protocols have therefore been developed where
the cells are first grown in unlabeled rich medium to high cell density
to later be transferred to a labeled medium for the expression phase.
This modification requires a few extra steps during cell culturing, but
reduces the costs associated with isotope labeling dramatically [90].
Full deuteration of the protein should also be considered for cer-
tain applications. Deuterating the protein could help increasing reso-
lution in protein NMR spectroscopy. Deuteration of the protein means
the hydrogens in the protein are not visible in the NMR spectrum
as 2H has a very different resonant frequency. In complex spectrum
with many peaks this is helpful as the amount of 1H contributes sig-
nificantly to peak broadening in larger proteins (e.g. >20kDa), which
congests the spectrum (further explained in Chapter 4) [91, 92].
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There is, however, still a need for the amide hydrogen to be 1H as
the sensitivity for proton experiments is much higher than for deu-
terium. Amide hydrogens are easily back-exchanged if sufficiently
exposed to the solvent. The most common approach is to grow the
cells and express the protein in a fully deuterated environment.
The host cells are therefore acclimatized to grow in D2O over sev-
eral cycles with increasing D2O concentration. In addition, some of
the precursors also need to be deuterated (for example [U-2H,13C-glucose]).
Normally the cell growth is slower in D2O-based medium, but the
protein yields are typically only slightly affected [92].
The protein is then expressed and purified as previously described
in normal aqueous buffers and the back-exchange occurs sponta-
neously for all solvent-exposed amides. For highly stable proteins
with low numbers of solvent-exposed amides, it could be beneficial
to investigate a potential de- and renaturation protocol of the protein
to fully back-exchange all amide-2H for 1H [92].
Deuteration further helps to increase the signal-to-noise ratio and
decrease signal overlap in the triple resonance experiments most com-
monly used for backbone assignment (more on this in Chapter 4)
[92]. These types of uniform labeling are a necessity for the backbone
assignment of large proteins, as was done in Papers I and II.
3.2 Amino acid-selective isotope labeling
3.2.1 Applications with amino acid-selectively labeled pro-
teins
Amino acid-selective labeling is a method used to gain more selec-
tive information. This could be certain amino acids involved in active
sites, or to follow the dynamics of specific protein parts in a time-
resolved manner.
Amino acid-specific labeling encompasses both labeling with iso-
tope variants of standard amino acids and unnatural amino acids,
and both techniques have been used for decades [10, 93, 94]. The in-
corporation of unnatural amino acids has the drawback of changing
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the chemical nature of the side chain, which could alter the nature of
the mechanism being investigated.
There are numerous examples of how the amino acid-selective
labeling technique have been used to gain a better understanding of
biochemical mechanisms. In Paper I and III we show two different
applications where amino acid-selective isotope labeling have been
utilized.
In Paper I, I selectively 13C,15N-label all lysines in two DrBphP
monomer samples containing either all lysines or with one lysine
mutated to alanine. With this we were able to unambiguously as-
sign and show changes in dynamics in the DrBphP tongue between
Pr and Pfr state.
In Paper III, we 13C-labeled all aspartic acids in an attempt to
elucidate how the isomerization of biliverdin couples to the global
structural rearrangement in DrBphP.
These two papers also detail two different ways to incorporate
isotope-labeled amino acids, and will also be explained in the fol-
lowing subsections.
Selective isotope labeling could also be used for systematic back-
bone assignment in NMR, by creating 19 different samples (as pro-
line does not contain an amide proton) each containing a different
labeled amino acid. This is a labor-intense and possibly expensive
way to decrowd the NMR spectrum [95].
There is also a number of combinatorial labeling methods, which
can be used to efficiently decrowd the spectrum [96–98].
Amino acid-selective labeling can in favorable cases also give site-
specific information. If the site of interest contain a unique sequence
which can be labeled, as was done by Professor Yokoyama and col-
leagues [99]. This labeling technique was explored within the work
of this thesis, but was put aside in favor of other techniques.
3.2.2 In vivo selective labeling
In vivo isotope labeling takes advantage of E. coli’s highly efficient
ability to take up exogenous compounds, in combination with growth
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in minimal medium. The procedure to express in vivo labeled pro-
teins follows the same principles as detailed in Chapter 2.
The minimal medium is supplied with all amino acids, exchang-
ing unlabeled with labeled equivalent (which are commercially avail-
able) at ones convenience. The addition of unlabeled amino acids
is important for the purpose of reducing isotopic scrambling. Iso-
topic scrambling is an effect from the bacterias efficient metabolic
pathways. It can utilize amino acids supplied in excess to produce
other amino acids in shortage and the isotope label can therefore
end up in sites not intended. The addition of excess unlabeled amino
acids tends to inhibit the metabolic pathways involved to some ex-
tent [95, 100].
In order to completely avoid scrambling, genetic manipulation
are required to provide strains auxotrophic for the enzymes involved
in the amino acid biosynthesis, and the need for special strains to
label certain difficult target amino acids is one of the drawbacks with
the in vivo labeling technique [101, 102]. However, once a suitable
host strain has been found or developed, in vivo labeling does have
the advantage over CFPE in the production of large and complex
proteins, and normally higher expression yields [103].
There are also in vivo labeling techniques taking advantage of
the metabolic pathways by introducing selectively labeled precur-
sors to label for instance methyl groups of methyl group-containing
amino acids. Or to label hydrophobic residues, employing the fact
that these amino acids are at the end point of their respective bio-
chemical pathways. This is very useful in NMR structure and dy-
namics studies [93, 104, 105].
3.2.3 Selective labeling with CFPE
The problem with isotope scrambling is not as pronounced with CFPE
due to lower metabolic activity, and the system can be highly opti-
mized to produce amino acid-selectively labeled protein [106]. The
general CFPE method is detailed in Chapter 2.
One labeling technique taking advantage of the much lower de-
gree of scrambling from CFPE is Stereo-Array Isotope Labeling which
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stereospecifically isotope label proteins for structure determination
[107].
The enzymes involved in the metabolism of the labeled amino
acids are present in the cell-free extract, but most of them do not get
regenerated and therefore the problem is not as severe. The amino
acids most subjected to scrambling in the CFPE are asparagine, as-
partic acid, glutamine, glutamic acid, serine and alanine. To deacti-
vate the metabolic enzymes it is possible to heat-treat the extract or
supplementing the reaction with inhibitors targeting these enzymes
[101]. Albeit with a slight loss in protein yields [108]. This was done
in Paper III where aminooxyacetic acid was added to avoid the degra-
dation of aspartic acid to glutamic acid.
The incorporation level of amino acids is generally low and with
the addition of isotopically labeled amino acids this tend to dramat-
ically increase the cost. Both for batch but especially for continuous-
flow and continuous-exchange cell-free systems where a continuous
supply of supplements is required [80, 106].
This can be mitigated by adjusting the concentrations of the la-
beled amino acids in relation to their occurrence in the primary se-
quence without affecting the labeled protein yields [79, 109]. Such
stoichiometric amino acid mixtures can be used to further reduce the
costs of labeling [77, 110].
3.3 Site-selective isotope labeling
Site-selective labeling of a single amino acid in the protein gives di-
rect insight into highly specific areas of the protein structure and its
dynamics. Not surprisingly, site-selective labeling has received a lot
of attention over the years.
The most straight-forward method for site-selective labeling is
peptide synthesis, and therefore the most widely used. The efficiency
of the synthesis however makes production of higher yields of large
proteins unfeasible. Even with 98% ligation efficiency the yield would
drop to 13% for a 100 amino acid long protein (or 0.004% for a 500
amino acid protein like DrBphP PAS-GAF-PHY).
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For some larger proteins it could be possible to ligate a synthe-
sized peptide to a truncated in vivo produced version of the protein
using native chemical ligation [111, 112]. This reaction was discov-
ered in 1953 and developed for peptide ligation in 1994 [113, 114].
Another way to label proteins site-specifically is to introduce un-
natural amino acids, using a chemically or enzymatically aminoa-
cylated suppressor tRNA, which recognizes the amber stop codon
(UAG), and CFPE. However, this is not feasible if the aim is to study
amino acids in the active site of the protein as they are likely to alter
the chemical nature of the amino acid in question [115, 116].
There is also a problem with the competing RF1 (Release Factor
1), which recognizes the amber stop codon and terminates transla-
tion, which dramatically lowers the yields of full-length proteins.
This was addressed by Otting and colleagues in 2012, when they re-
placed the wild-type RF1 with a Chitin Binding Domain-tagged RF1,
allowing for affinity chromatographic removal of RF1 from the cell-
free extract [117].
3.3.1 Principles of site-selective labeling
CFPE is the most widely used technique for site-selective labeling, as
it has the advantages of being an open system and thus easy to mod-
ify. As site-selective labeling requires the loading of the suppressor
tRNA with an aminoacyl group by chemical ligation, the open sys-
tem is a huge benefit.
There is a number of strategies regarding this: either utilizing a
modified aminoacyl tRNA synthetase (aaRS) which recognizes the
specified amino acid, or with the T4 RNA ligase 1 reaction, as was
first reported by Hecht et al. in 1978 [118], and is further explained
below.
A truncated suppressor tRNA is transcribed in a so-called "run-
off transcription" where transcription is performed with an enzymat-
ically (Fok1) digested and thus linearized DNA plasmid resulting in
the tRNA lacking the last two nucleotides (-CA) [119]. Instead a din-
ucleotide (pdCpA) fragment is chemically aminoacylated with the
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amino acid of choice. An efficient way to aminoacylate the pdCpA
fragment has previously been reported [120].
Amino acid amides and functional side chain groups are accessi-
ble for side reactions and must be chemically protected. For amino
acids without side chain functionality, the 4-pentenoyl group, which
is labile in aqueous iodine can be used. While for amino acids with
side chain functionality, 6-nitroveratryloxycarbonyl and 2-nitrobenzyl,
which are both susceptible to photolysis, can be used to protect the
amide groups and side chains, respectively [120, 121]. Various other
protection groups have been explored but are not mentioned here.
The aa-pdCpA is then ligated to the truncated tRNA(-CA) with
the help of T4 RNA ligase 1, deprotected with either iodine solution
or light exposure and flash frozen. After deprotection of the amide
group, the aminoacyl-tRNA ester linkage is susceptible to hydrolysis
and start degrading to full-length tRNA and free amino acid. This is
also one of the reasons to include protection groups from the start, as
the hydrolysis reaction is much faster than the ligation reaction [122].
This method of introducing site-selective labels can be used with
both unnatural and isotope-labeled amino acids. It does not require
the aaRS, which has highly specific recognition sites for both the spe-
cific amino acid and its respective tRNA and would require struc-
tural modifications to allow for unnatural amino acids. The T4 RNA
ligase method is therefore a general method, as compared to the aaRS.
[120].
The above described method was used for Paper IV to site-specifically
isotope label tyrosine 66 in GFP. A schematic view of the site-selective
labeling used in Paper IV can be seen in Figure 3.1.
In vivo site-selective labeling has been quite heavily studied and
developed over the years. A lot of work has gone into developing
aaRS to accommodate a huge variety of unnatural amino acids and
ligating these to amber suppressor tRNA or other modified tRNAs
[117, 123].
A big advantage of the in vivo site-selective labeling is that it re-
alizes the possibility to site-specifically monitor a protein in living
cells. Unfortunately the problem of a competing RF1 still remains
and can drastically reduce the yields of full-length protein. There has
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Figure 3.1: Site-selective labeling of proteins with CFPE A schematic view
of the experimental principle applied to produce site-selectively labeled pro-
tein. Abbreviations: AA (amino acid), RF1 (release factor 1), PG (protection
group), pdCpA (5’-O-phosphoryl-2’-deoxycytidylyl-(3’→5’)adenosine). Fig-
ure adapted from Paper IV.
been attempts to remedy this, although to no greater success as the
complete removal of RF1 is normally lethal to the host cell [124].
Further complications include the problems of incorporating isotope-
labeled instead of unnatural amino acids, as the native aaRS cannot
distinguish between the native and isotope-labeled amino acids. In
very specific cases it has been possible to introduce a labeled pho-
toreactive unnatural amino acid, which upon radiation and after in-
corporation decages an isotope-labeled natural amino acid [125–127].
Since unnatural amino acids tend to have altered chemical proper-
ties, the use in probing functional sites is limited.
3.4 Summary
A large number of techniques for isotope-labeling exist, many devel-
oped to solve a specific challenge. I have used a combination of uni-
form, amino acid-selective and site-selective labeling in this work.
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By uniformly isotope labeling a DrBphP monomer, we have in
Paper I been able to perform backbone assignment with NMR spec-
troscopy. This, together with amino acid-selective labeling, has re-
vealed that the tongue arms form an α-helix and β-sheet in Pfr form,
while being highly dynamic in Pr. This indicates that changes in struc-
tural dynamics of the tongue region are coupled to the photomodu-
lation of phytochromes.
Uniform labeling has also made it possible to investigate the knot
region in Paper II. We detect major changes between Pr and Pfr and
suggests this as a novel signaling route in phytochromes.
In addition we uniformly isotope labeled the DrBphP apoprotein
in Paper III to detail how the isomerization of the chromophore cou-
ples to global structural rearrangements in the photosensory recep-
tor.
By using amino acid-selective isotope-labeling we could assign
a band to the chromophore D-ring in Meta-R state by excluding a
protonated aspartic acid 207 as the origin, as described in Paper III.
In Paper IV, we site-selectively isotope labeled tyrosine 66 in the
chromophore of GFP, and were able to unambiguously confirm the
existence of an intermediate state between photoexcitation and de-
protonation of tyrosine 66, as had previously been proposed [42, 43].
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Chapter 4
Spectroscopy
This chapter will give a short description on the different spectro-
scopic techniques which have been used during the work on this
thesis. Section 4.1 will give a brief introduction to NMR spectroscopy
and list the various NMR experiments used. Section 4.2 will be the
equivalent for infrared spectroscopy, and Section 4.3 will summarize
this chapter.
4.1 NMR spectroscopy of proteins
NMR spectroscopy was independently developed by two different
groups lead by Dr. Purcell at Harvard University and Dr. Bloch at
Stanford University, for which they shared the Nobel Prize in physics
in 1952 [128, 129]. They in turn had based their research on the find-
ings of Dr. Rabi who is credited with discovering Nuclear Magnetic
Resonance in the 1930’s, and who received the Nobel Prize in physics
in 1944.
Over the following 10 years, NMR spectroscopy continued to de-
velop and in 1957 the first NMR spectrum of a protein was recorded
[130]. This was shortly before the first crystal structure of a protein
was revealed, and the dream of using NMR in solving protein struc-
tures was born [4]. But it would take until 1985 before the first 3D-
structure was solved by Wüthrich et al [131], who later would receive
the Nobel Prize for his work. Ever since then, NMR has been a pow-
erful tool to solve structures of proteins in solution and as of 2017,
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over 12000 structures by NMR have been deposited in the protein
data bank [2].
4.1.1 Short theory of protein NMR
NMR spectroscopy uses the intrinsic spin (or spin angular momen-
tum) of a nucleus. This is a quantum mechanical property of certain
elementary particles and as nuclei consist of these elementary par-
ticles they too can have spins. The spin of a nucleus can also have
different states, which have the same energy in the absence of an ex-
ternal magnetic field.
Classically, the spin of a nucleus can be viewed as the nucleus
spinning around its own axis. Not all nuclei are magnetically active
though, and thus can not be detected by NMR. Spinning charged
particles create a magnetic field around them, and as such have a
magnetic moment, which is closely linked to their spin.
An NMR spectrometer is in essence an extremely strong magnet,
equipped to send and receive radiofrequency (RF) waves, with mag-
netic fields tens of thousands times stronger than the Earth’s mag-
netic field. The sample is immersed in this strong field, and the nu-
clei magnetic moments align with the magnetic field direction of the
spectrometer.
This causes the energy levels of the nucleus spin states to shift,
which creates an energy gap. The energy required to transition be-
tween these states is dependent on the magnetic field strength expe-
rienced by the nucleus. In a molecule this depends not only on the
magnetic field of the spectrometer but also the local electron distribu-
tion in the molecule contribute. Therefore, two different hydrogens
in a molecule can have slightly different RF resonant energies (or res-
onant frequencies).
This effect is called chemical shift, and is one of the reasons NMR
have become so widely used in protein science. The chemical shift
makes it possible to follow events in proteins at atomic resolution.
The chemical shift is defined as the relation of the resonant frequency
of the nucleus of interest (v) to a reference nucleus (vref ) which varies
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between the different measured nuclei, and is given as parts per mil-
lion (ppm).
δ = 106 ∗ (v − vref )
vref
Analysis of the carbon chemical shifts are often used to reveal
the secondary structure. By subtracting a so-called random coil shift
value, it is possible to distinguish between regions having a propen-
sity for α-helical or β-strand structure [7, 132]. This analysis, called
secondary chemical shift analysis, can be used to determine secondary
structure, or changes in secondary structure between two protein
states.
Further analysis from chemical shifts useful for protein NMR spec-
troscopy is chemical shift perturbation. The amides of proteins are
very sensitive to changes in local magnetic environment, giving large
chemical shifts. Chemical shift perturbation follows the changes in
chemical shifts occuring from ligand binding or changes in structure
between different states [133].
Spin-spin coupling is another great source of information in pro-
tein NMR, which arises from the different spin states of a nucleus
and how those different spin states are "felt" by other nearby nuclei.
This gives rise to splitting of peaks, which increases the amount of
information but also makes a more complex spectrum which could
present a difficulty in the already crowded spectra of protein molecules.
In protein NMR spectroscopy, many experiments are therefore
performed in a decoupled manner. Decoupling the 1H-13C-coupling,
as an example, is performed by irradiating the sample with 1H res-
onance frequency during the recording of the 13C signal and thus
removes the splitting of the 13C signal.
The major contribution to the spin-spin coupling is called the
J-coupling (or scalar coupling) and is for a specific coupling always
the same. However, the information contained in the splitting of peaks
can be very useful for structure determination as it also gives infor-
mation about the dipolar couplings of two nuclei. The dipolar cou-
pling of two nuclei depends on the orientation and magnitude of
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their magnetic moments, and the vector which describes their rela-
tive positions in relation to the magnetic field.
As the molecules in an isotropic solution tumble, the dipolar cou-
pling contribution gets averaged out and cannot be measured. This
can be solved with the addition of alignment medium to the protein
solution which partially aligns the molecules and creates an anisotropic
non-zero signal that is measurable and called residual dipolar cou-
pling (RDC). [134–137].
As RDCs give information on the relative vector of chemical bonds,
they can be used to refine crystal or NMR structures, investigate pro-
tein dynamics or even solve structures de novo [136–138].
Spin relaxation is the most common way to measure dynamics
in protein NMR spectroscopy. The energy difference between a nu-
cleus spin states provides the possibility to "flip" a spin from one
low energy state to a high energy state with the help of a RF pulse.
As the system returns to thermal equilibrium, the energy from high
energy spin states dissipates out into the surroundings (or "lattice").
The lattice can be lower energy spin states, vibrational and rotational
motion. The relaxation speed is very much dependent on changes to
the local environment and T1 relaxation (also called spin-lattice re-
laxation) experiments measure these relaxation rates.
As the RF pulse is delivered and the spin states flipped, the spins
are in phase with each other. Depending on the local magnetic envi-
ronment, i.e. other local spin systems, the spins return to equilibrium
with different decay times and therefore ends up out of phase. T2
relaxation (or spin-spin relaxation) experiments measure these de-
phasing (or phase randomization) times.
This is a short summary of different NMR experiments used in
this work. For a more thorough explanation of the theory behind
NMR spectroscopy, see Levitt [139] and Keeler [140].
4.1.2 Multidimensional protein NMR spectroscopy
One of the most frequently used experiments in NMR spectroscopy
on large protein is TROSY (transverse relaxation optimized spectroscopy).
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It is a two-dimensional experiment with one axis presenting the pro-
ton frequency and the other axis either carbon or nitrogen frequency
(See Figure 4.1 for an example of a [1H,15N]-TROSY).
As can be imagined, the addition of another dimension helps
tremendously with signal overlap. It has become widely used as a
"fingerprint" of the protein to evaluate whether more advanced and
time-consuming experiments are feasible.
2D-experiments take advantage of the fact that spin polarization
(or magnetization) can be transferred from one spin to another cou-
pled spin, either through bonds or space. A heteronuclear experi-
ment couples protons to other types of nuclei such as 13C or 15N.
[1H,15N]-TROSY is particularly useful in protein NMR as all amino
acids besides proline have one proton coupled to a nitrogen in the
amide group. The number of peaks in relation to the size of the pro-
tein, and the peak distribution and line width of the peaks gives a
clue as to the possibilities of recording higher dimensional spectra.
Resonance assignment of amino acids is necessary in order to ex-
tract residue-specific information from the NMR data. For large pro-
teins, two dimensions is not enough to fully resolve all the different
peaks, and some way to link sequential residues is needed.
Multidimensional triple resonance experiments require samples
uniformly labeled with 13C and 15N, as they transfer the magnetiza-
tion from the amide proton to the amide nitrogen as the first detec-
tion step. In the case of a HNCA experiment, the magnetization is
further transferred to the α-carbon as the second detection step, and
last back to the amide proton for the third and final dimension.
As can be seen in Figure 4.2, the magnetization transfers to both
residue i and residue i-1 and gives both internal and sequential in-
formation. This combination is the basis of backbone assignment, as
it gives the possibility to connect a sequence of residues.
Triple resonance experiments often used also include detection of
β-carbon (HNCACB) or carbonyl-carbon (HNCO), and experiments
specifically designed to detect sequential information (HN(CO)CA,
HN(CO)CACB and HNCACO) [141,142]. These experiments are nor-
mally used in tandem or in pairs (HNCA and HN(CO)CA) for back-
bone assignment of proteins.
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Figure 4.1: [1H,15N]-TROSY of DrBphP monomer in Pr state, each peak rep-
resenting one amide group. Here the proton frequency is represented on the
vertical axis and nitrogen frequency on the horizontal axis.
The backbone assignment can to some extent be done automati-
cally with programs such as FLYA or AutoAssign [143,144]. For large
proteins there is still a need to manually go through the assignment,
linking each internal signal with the sequential signal.
For Paper I and II we recorded the following triple-resonance
experiments: HNCA, HN(CO)CA, HNCACB, HN(CO)CB, HNCO,
HNCACO and [1H,15N]-NOESY, for a 509 residue DrBphP PAS-GAF-
PHY monomer in both Pr and Pfr states. Backbone assignment was
performed both using Targeted Acquisition, an automated non-uniform
sampling and assignment program [145–147], and manual assign-
ment.
From the secondary chemical shift analysis, we could in Paper I
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Figure 4.2: HNCA magnetization transfer. As can be seen, the experiment
also recognizes the residue i-1 α-carbon (dashed line), and thus gives se-
quential information in addition to internal couplings. This is used for link-
ing sequential residues in the protein.
show that while the second arm of the DrBphP tongue folds as an
α-helix, the first arm is a stable β-strand in Pfr state.
The tongue is highly dynamic in Pr state as evident from the data
collected on DrBphP with isotope-labeled lysines. The disappearance
of a signal for the tongue lysine (K476) strongly suggests micro- to
millisecond structural dynamics.
While secondary chemical shift analysis showed no change in
secondary structure for the knot region (Paper II), chemical shift per-
turbation revealed major changes in the knot and helical spine. The
residues showing the largest changes are located between the biliverdin
and helical spine, and could manifest a new signaling pathway in
phytochromes.
Further, RDC measurements on both states were made using bac-
teriophage Pf1 as alignment media. These showed good correlation
between Pr crystal structure and observed Pr state data, but poor cor-
relation to the Pfr structure. This can be interpreted that the crystal
structure of Pfr state is a poor approximation of the solution state
structure.
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4.2 Infrared spectroscopy of proteins
4.2.1 History of vibrational spectroscopy
Infrared (one type of vibrational) spectroscopy dates back to the dis-
covery of IR (infrared) radiation in 1800 by Sir William Herschel
[148]. Following Sir Isaac Newtons first spectroscopic experiments
in the 1600’s [149], in the late 1800’s and early 1900’s IR spectra of
hundreds of compounds were recorded.
It was among others noted that methyl groups absorb IR at char-
acteristic wavelengths, and in the following hundred years IR spec-
troscopy developed into an extremely powerful tool for analyzing
small molecules. The infrared spectrum is very information rich, and
has therefore also been applied to larger molecules such as proteins.
IR spectroscopy is just one of a few different spectroscopic tech-
niques that qualify as vibrational, others are for instance Raman and
photoacoustic spectroscopy [86]. However, these will not be detailed
further in this work.
4.2.2 Short theory of protein IR spectroscopy
Vibrational spectroscopy probes the molecular absorption energy at
different resonant frequencies. These resonant frequencies arise from
vibrations in chemical bonds, so called vibrational modes, such as
stretching and bending of the bond.
In order for IR spectroscopy to pick up the chemical bond vi-
brations, there need to be a change in dipole moment. Symmetric
molecules, such as N2, are therefore not "IR active". The resonant fre-
quencies of vibrational modes follows Hooke’s law which states that
the resonant frequency (f ) is proportional to the bond strength (k)
and inversely proportional to the reduced mass (m1 and m2) of the
bonded atoms (see Figure 4.3a).
f =
1
2pi
√
k
µ
µ =
m1m2
m1 +m2
48
4.2. Infrared spectroscopy of proteins
As the environment (inter- and intramolecular effects) influences
the frequency and dipole moments, vibrational spectra contain in-
formation on the chemical environment of the absorbing group. The
absorption bands in an IR spectrum give information on the chemical
structure of the molecule [86].
Non-linear molecules, such as proteins, with N number of atoms
have 3N − 6 vibrational modes, and thus the spectra are extremely
information rich but gets very crowded and assignment of the indi-
vidual spectral peaks is a formidable task.
In larger molecules, such as proteins, the spectra are congested
but some bands stand out as particularly strong. The main peptide
chain amide I (mainly C=O stretching) and amide II (mainly N-H
bending and C-N stretching) bands are among these. All residues
contribute to these vibrations. Figure 4.3b depicts the origin of the
amide I and II bands.
Figure 4.3: Vibrational bands arise from the resonant frequencies which fol-
low Hooke’s law regarding bond strength (k) and the mass of the bonded
atoms (m1 and m2) seen in panel a. In panel b the origin of amide I and II
vibrations are shown.
Several variants of IR spectroscopy has been developed. Two meth-
ods covered here are time-resolved FTIR and femtosecond infrared
spectroscopy (or transient absorption spectroscopy).
FTIR differs from traditional absorption techniques in that it col-
lects the entire spectral range simultaneously as interferograms. The
beam is split and diverted to either a fixed mirror or a mirror which is
moved discrete distances between each measurement. As the beams
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are reflected back and recombined they are out of phase due to the
shifted position of the mirror. This creates varying constructive or de-
structive interference. The beam is then passed through the sample
and some frequencies are absorbed. This is repeated for several mir-
ror positions, and the changes in the interferogram are then Fourier
transformed (hence FT-IR) into a spectrum.
The two main advantages using FTIR is the higher signal-to-noise
ratio and the greater speed at which a spectrum can be recorded.
For standard measurements, FTIR has become the method of choice.
Traditional absorption techniques find their uses in the time-resolved
methods further detailed in the coming subsections.
As almost all molecules give rise to absorption bands in the IR
spectrum, isotope labeling may seem a bit redundant. But inspect-
ing Hooke’s law and the equation for reduced mass shows that an
increase in atomic mass shifts the vibrational band to a lower fre-
quency. This possibility to shift peaks in the spectrum can be ex-
tremely useful, as assignment of the peaks in a congested spectrum
is so difficult.
By labeling only selected parts of a protein, the absorption bands
from the selected region can be resolved from the congested spectra
due to their spectral shifts.
The isotopic shift is hard to predict, the contribution to the ab-
sorbance from each atom is not cleary defined. They can to some ex-
tent be guided by DFT (density functional theory) calculations as was
done in Paper IV. Several labeling schemes were proposed and the
selection was guided by which scheme showed the largest calculated
isotopic shift.
4.2.3 Probing structural changes by IR spectroscopy
In IR spectroscopy, proteins give rise to a number of bands from the
amide groups (amide A, B and I-VII), originating from the main pep-
tide chain [150]. In addition, all side chains have their particular set
of vibrational bands in the spectrum, which also are affected by the
local chemical environment. Infrared spectrum for all amino acids
has been reported by Hellwig [151] and Barth [86], and even though
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the bands can shift dramatically in the protein context these studies
can serve as guidelines when trying to assign protein bands.
When talking about the local chemical environment, there are
several factors that contribute to the shifting of bands. The major con-
tributor comes from the chemical structure of the vibrating group.
The chemical structure changes with, for example, protonation or re-
dox state of the group. The chemical structure of neighboring groups,
hydrogen bonding, electric fields and bond strengths and angles also
contribute. Any of these changes will get picked up in the IR spec-
trum as a change in the absorption bands to a lesser or larger extent.
In order to filter out changes from the heavily congested spec-
trum it could be useful to measure difference spectra. A difference
spectrum would give information only on changes in the vibrational
modes. Negative peaks (or bleaches) represent a decrease in the pop-
ulation of a state and positive peaks an increase. Difference measure-
ments present a way to decrowd spectra where changes in structure
or local chemical environment occur.
This can be done as so-called steady-state, where a final state
spectrum is compared to an initial state spectrum, giving information
on changes between two discrete states. It can also be done at discrete
time-points along the reaction, which will yield a time-resolved IR
experiment, in order to follow the reaction in a time-resolved man-
ner. Two types of time-resolved experiments used in this work will
be detailed in the following subsections.
4.2.4 Step-scan FTIR of proteins
Step-scan FTIR spectroscopy is a time-resolved FTIR experiment op-
erating in the tens of nanoseconds to hundreds of milliseconds time
regime. It makes use of the higher signal-to-noise and measurement
speeds of the FTIR, as changes in absorbance tend to be very signal
weak and require several cycles of measurement.
It functions by detecting the decay of signal over time at each
mirror position. The time-resolution is thus dependent on the detec-
tor response time and how fast the transient recorder can convert the
signal to a digital one.
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The need for several consecutive measurements at different mir-
ror positions and signal averaging to increase signal-to-noise ratio
puts a high demand on the sample to tolerate being pushed back and
forth between initial and final states for up to several hours. Alterna-
tively the sample can be exchanged for a spectroscopically identical
sample after each cycle [152–155].
In Paper III we apply this technique in order to resolve how the
isomerization of the chromophore couples to the global structural re-
arrangement of DrBphP. We performed time-resolved step-scan FTIR
on both monomeric and dimeric DrBphP photosensory module. The
protein was pushed between the two meta-stable Pr and Pfr states,
and spectra were recorded with a time-resolution of 2.5µs.
4.2.5 Ultra-fast IR spectroscopy of proteins
Many photochemical reactions take place at timescales shorter than
step-scan FTIR is able to detect. For this purpose femtosecond tran-
sient IR spectroscopy has become a method of choice. With this tech-
nique it is possible to follow reactions on a femtosecond timescale,
up to the nanoseconds.
A short pump-pulse is generated, which excites the sample fol-
lowed by a probe-pulse, and difference in absorption is measured be-
tween pump-on and pump-off. The timing between pump and probe
pulses (delay time) is varied by changing the optical path length of
the pump-pulse. Repeating the measurement for several different de-
lay times gives a change in difference spectra, and thus information
on the reaction, over time. Presently, however, the technique is lim-
ited to proteins and protein reactions which can be triggered by a
laser flash.
In Paper IV femtosecond IR spectroscopy was used, in combi-
nation with site-selective isotope labeling of tyrosine 66 in GFP. We
could unambiguously identify a short-lived (3ps) intermediate state
between photoexcitation and deprotonation of tyrosine 66.
The application range for IR spectroscopy is huge and for deeper
insights into other vibrational spectroscopy techniques than for biomolecules
and the theory behind, see Stuart [156].
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4.3 Summary
Various spectroscopic techniques have long been used to probe struc-
tural dynamics of proteins in solution.
We used solution NMR spectroscopy to follow structural dynam-
ics in DrBphP. In Paper I we show how changes in structural dy-
namics of the tongue region is used in photomodulation of phy-
tochromes.
In Paper II we use solution NMR spectroscopy to investigate the
knot region as a possible novel signaling pathway of phytochromes.
Step-scan FTIR experiments was used in Paper III to show how
isomerization of the biliverdin chromophore couples to global struc-
tural rearrangements in DrBphP.
In Paper IV femtosecond IR spectroscopy revealed a previously
proposed intermediate state in GFP.
The results given here give an insight into what can be achieved
with the vast collection of spectroscopic applications available for
protein science.
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Concluding remarks
All the work conducted in the making of this thesis (with exception
of Paper V) have been probing structural dynamic events in proteins.
Most of the work has been carried out using a range of isotope label-
ing schemes and spectroscopic techniques.
The large number of techniques for labeling proteins with either
isotopes or unnatural amino acids, in combination with the various
spectroscopic techniques available, result in almost endless possibil-
ities to investigate protein structural dynamics.
Solution NMR spectroscopy has long been used to investigate
proteins, and solve their structures. In Paper I we investigate the
changes in structural dynamics of DrBphP tongue region. We show
that the tongue is highly dynamic in Pr state and assumes a stable
α-helix and β-strand in Pfr state. This suggests photomodulation of
phytochromes is coupled to structural heterogeneity and changes in
structural dynamics from soft-to-rigid.
These conclusions were aided by the amino acid-selective label-
ing of lysines in the protein, which revealed structural dynamics in
the Pr state tongue region on a micro- to millisecond timescale.
In Paper II we use a selection of solution NMR spectroscopy ex-
periments to investigate the knot region in the PAS-GAF bidomain.
Changes in amide chemical shifts reveal large changes in structure
between Pr and Pfr state. Secondary chemical shifts show that these
changes are not coupled to changes in secondary structure.
RDC experiments also reveal a poor correlation between solu-
tion and crystal structures of the Pfr state. Further RDC experiments
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will make it possible to refine the solution structural change of the
DrBphP PAS-GAF-PHY.
Two types of time-resolved infrared spectroscopic techniques were
also used in this thesis.
Step-scan FTIR revealed how the isomerization of biliverdin cou-
ples to global structural rearrangements in DrBphP in Paper III. Uni-
form isotope labeling of the apoprotein allowed us to distinguish the
protein absorption bands from those of the biliverdin.
Femtosecond IR spectroscopy was used to investigate the initial
events after photoexcitation in GFP (Paper IV). By site-specifically la-
beling tyrosine 66, we could identify a previously proposed interme-
diate state between photoexcitation of tyrosine 66 and proton trans-
fer.
This site-specific labeling protocol can be used for other proteins
in order to highly selectively monitor the active site or specific residues
role in chemical reactions.
In Paper V we could also detail a CFPE system able to produce a
functional pore-only sodium channel membrane protein. Site-specific
labeling could in the future reveal how sodium transport is conducted
over the membrane on a molecular level.
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